Related references
Note: Only part of the references are listed.Autosomal dominant sleep-related hypermotor epilepsy caused by a previously unreported CHRNA4 variant
Trine Ostergaard Nielsen et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)
PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Solveig Tiepolt et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
A tonic nicotinic brake controls spike timing in striatal spiny projection neurons
Lior Matityahu et al.
ELIFE (2022)
Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids
Omar Alijevic et al.
FRONTIERS IN PHARMACOLOGY (2022)
Current and emerging pharmacotherapeutic strategies for Tourette syndrome
Andrea E. Cavanna
EXPERT OPINION ON PHARMACOTHERAPY (2022)
The β2V287L nicotinic subunit linked to sleep-related epilepsy differently affects fast-spiking and regular spiking somatostatin-expressing neurons in murine prefrontal cortex
Simone Meneghini et al.
PROGRESS IN NEUROBIOLOGY (2022)
Genetic Variant in Nicotinic Receptor α4-Subunit Causes Sleep-Related Hyperkinetic Epilepsy via Increased Channel Opening
Simone Mazzaferro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Diagnosis and Management of Functional Tic-Like Phenomena
Irene A. Malaty et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Nicotine: A Targeted Therapy for Epilepsy Due to nAChR Gene Variants
Jordana Fox et al.
JOURNAL OF CHILD NEUROLOGY (2021)
Precision treatment with nicotine in autosomal dominant sleep-related hypermotor epilepsy (ADSHE): An observational study of clinical outcome and serum cotinine levels in 17 patients
Eylert Brodtkorb et al.
EPILEPSY RESEARCH (2021)
Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders
Steven R. Laviolette
NEUROPHARMACOLOGY (2021)
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety
Claire Nguyen et al.
NEURON (2021)
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
Antonella Fattorusso et al.
FRONTIERS IN NEUROLOGY (2021)
High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using 18F-ASEM PET
Jennifer M. Coughlin et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor
Kouji Fukuyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Trends in the Prevalence of Current, Daily, and Nondaily Cigarette Smoking and Quit Ratios by Depression Status in the US: 2005-2017
Andrea H. Weinberger et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)
Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy
Kristine Lossius et al.
EPILEPSY & BEHAVIOR (2020)
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors
Benjamin Mappin-Kasirer et al.
NEUROLOGY (2020)
α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry et al.
NEUROPHARMACOLOGY (2020)
CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease
Kinga Szigeti et al.
EBIOMEDICINE (2020)
Cholinergic modulation of striatal microcircuits
Nilupaer Abudukeyoumu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Maryka Quik et al.
NICOTINE & TOBACCO RESEARCH (2019)
Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia
Jason R. Tregellas et al.
NICOTINE & TOBACCO RESEARCH (2019)
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Stephanie C. Dulawa et al.
MOLECULAR PSYCHIATRY (2019)
Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update
Justin L. Hoskin et al.
NICOTINE & TOBACCO RESEARCH (2019)
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Alvin V. Terry et al.
NICOTINE & TOBACCO RESEARCH (2019)
Global proteomic profiling of the uniquely human CHRFAM7A gene in transgenic mouse brain
Yu Jiang et al.
GENE (2019)
Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry
Dinesh C. Indurthi et al.
PHARMACOLOGICAL RESEARCH (2019)
Molecular function of 7 nicotinic receptors as drug targets
Cecilia Bouzat et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
The wonderland of neuronal nicotinic acetylcholine receptors
Daniel Bertrand et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer’s Disease
Kyoko Nakaizumi et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
A human-specific, truncated 7 nicotinic receptor subunit assembles with full-length 7 and forms functional receptors with different stoichiometries
Matias Lasala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Nicotine exposure leads to deficits in differential cued fear conditioning in mice and humans: A potential role of the anterior cingulate cortex
Munir Gunes Kutlu et al.
NEUROSCIENCE LETTERS (2018)
Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2018)
Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors
Nadine Kabbani et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging
Jason Smucny et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Acute Worsening of Tics on Varenicline
Shivam Om Mittal et al.
CLINICAL NEUROPHARMACOLOGY (2017)
Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging
David L. Sultzer et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Transcriptome Analysis of the Human Striatum in Tourette Syndrome
Jessica B. Lennington et al.
BIOLOGICAL PSYCHIATRY (2016)
X-ray structure of the human α4β2 nicotinic receptor
Claudio L. Morales-Perez et al.
NATURE (2016)
Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample
A. Mobascher et al.
PLOS ONE (2016)
CHRNA7 and CHRFAM7A mRNAs: Co-Localized and Their Expression Levels Altered in the Postmortem Dorsolateral Prefrontal Cortex in Major Psychiatric Disorders
Yasuto Kunii et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders
Alvin V. Terry et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors
S. M. Anderson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy
Marina Trivisano et al.
EPILEPSIA (2015)
High-throughput analysis of behavior for drug discovery
Vadim Alexandrov et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function
Valerio Conti et al.
NEUROLOGY (2015)
Inside-out neuropharmacology of nicotinic drugs
Brandon J. Henderson et al.
NEUROPHARMACOLOGY (2015)
Spontaneous epileptic seizures in transgenic rats harboring a human ADNFLE missense mutation in the β2-subunit of the nicotinic acetylcholine receptor
Yuko Shiba et al.
NEUROSCIENCE RESEARCH (2015)
Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome
Meiyu Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease
R. Lorenz et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
In Vivo Evidence for β2 Nicotinic Acetylcholine Receptor Subunit Upregulation in Smokers as Compared With Nonsmokers With Schizophrenia
Irina Esterlis et al.
BIOLOGICAL PSYCHIATRY (2014)
Mult-electrode array study of neuronal cultures expressing nicotinic β2-V287L subunits, linked to autosonnal dominant nocturnal frontal lobe epilepsy. An in vitro model of spontaneous epilepsy
Francesca Gullo et al.
FRONTIERS IN NEURAL CIRCUITS (2014)
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease
Ioannis Ugo Isaias et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Changes in the Cholinergic System between Bipolar Depression and Euthymia as Measured with [123I]5IA Single Photon Emission Computed Tomography
Jonas O. Hannestad et al.
BIOLOGICAL PSYCHIATRY (2013)
Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology
Hiroyuki Okada et al.
BRAIN (2013)
Layer-Specific Modulation of the Prefrontal Cortex by Nicotinic Acetylcholine Receptors
Rogier B. Poorthuis et al.
CEREBRAL CORTEX (2013)
The pharmacology of Tourette syndrome
Roji Thomas et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Prenatal Exposure to Nicotine Stimulates Neurogenesis of Orexigenic Peptide-Expressing Neurons in Hypothalamus and Amygdala
Guo-Qing Chang et al.
JOURNAL OF NEUROSCIENCE (2013)
Pharmacological treatment of tic disorders and Tourette Syndrome
Veit Roessner et al.
NEUROPHARMACOLOGY (2013)
Mice expressing the ADNFLE valine 287 leucine mutation of the B2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function
Heidi C. O'Neill et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Lower β2*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia
Deepak Cyril D'Souza et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder
Aybala Saricicek et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
Alastair J. Noyce et al.
ANNALS OF NEUROLOGY (2012)
Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides
Qiang Liu et al.
BMC NEUROSCIENCE (2012)
α7 Nicotinic Acetylcholine Receptors in Alzheimer's Disease: Neuroprotective, Neurotrophic or Both?
Caterina M. Hernandez et al.
CURRENT DRUG TARGETS (2012)
A case of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) coexisting with pervasive developmental disorder harboring SCN1A mutation in addition to CHRNB2 mutation
Daichi Sone et al.
EPILEPSY & BEHAVIOR (2012)
Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABAB1 knockout mice
Andres P. Varani et al.
NEUROPHARMACOLOGY (2012)
Translating laboratory discovery to the clinic: From nicotine and mecamylamine to Tourette's, depression, and beyond
Paul R. Sanberg et al.
PHYSIOLOGY & BEHAVIOR (2012)
Low Dose Nicotine and Antagonism of β2 Subunit Containing Nicotinic Acetylcholine Receptors Have Similar Effects on Affective Behavior in Mice
Shawn M. Anderson et al.
PLOS ONE (2012)
The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development
Noah S. Philip et al.
SCIENTIFIC WORLD JOURNAL (2012)
Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
H. Rheinallt Parri et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function
Tanguy Araud et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The identification of a novel mutation of nicotinic acetylcholine receptor gene CHRNB2 in a Chinese patient: Its possible implication in non-familial nocturnal frontal lobe epilepsy
Hui Liu et al.
EPILEPSY RESEARCH (2011)
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography
Kai Kendziorra et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
α4β2 Nicotinic Acetylcholine Receptors on Dopaminergic Neurons Mediate Nicotine Reward and Anxiety Relief
Tresa M. McGranahan et al.
JOURNAL OF NEUROSCIENCE (2011)
Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test
Jesper T. Andreasen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline
Jesper T. Andreasen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
Barbara J. Caldarone et al.
PSYCHOPHARMACOLOGY (2011)
Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior
Jill R. Turner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
Lisa M. Shin et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior
Amy K. Eppolito et al.
NEUROTOXICOLOGY AND TERATOLOGY (2010)
Nicotinic receptor channelopathies and epilepsy
Ortrud K. Steinlein et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature
Noah S. Philip et al.
PSYCHOPHARMACOLOGY (2010)
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Yann S. Mineur et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Reduced α4β2*-Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
Philipp M. Meyer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Cortical α7 Nicotinic Acetylcholine Receptor and β-Amyloid Levels in Early Alzheimer Disease
Milos D. Ikonomovic et al.
ARCHIVES OF NEUROLOGY (2009)
Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex
Jesper T. Andreasen et al.
BEHAVIOURAL PHARMACOLOGY (2009)
A 2-base pair deletion polymorphism in the partial duplication of the α7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia
Melissa L. Sinkus et al.
BRAIN RESEARCH (2009)
Comorbidity, health screening, and quality of life among persons with a history of epilepsy
John O. Elliott et al.
EPILEPSY & BEHAVIOR (2009)
Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene
Jean-Charles Hoda et al.
FEBS LETTERS (2009)
Expression of mutant β2 nicotinic receptors during development is crucial for epileptogenesis
Irene Manfredi et al.
HUMAN MOLECULAR GENETICS (2009)
Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease
Aurelie Kas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides
Qiang Liu et al.
JOURNAL OF NEUROSCIENCE (2009)
Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development
Jerry J. Buccafusco et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests
J. T. Andreasen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures
H. Kurahashi et al.
NEUROLOGY (2009)
Diversity of vertebrate nicotinic acetylcholine receptors
Neil S. Millar et al.
NEUROPHARMACOLOGY (2009)
Self-perceived smoking motives and their correlates in a general population sample
Jennifer A. Fidler et al.
NICOTINE & TOBACCO RESEARCH (2009)
Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia
Sarah H. Stephens et al.
SCHIZOPHRENIA RESEARCH (2009)
CHRNA2 mutations are rare in the NFLE population: Evaluation of a large cohort of Italian patients
Romina Combi et al.
SLEEP MEDICINE (2009)
Acetylcholine receptors in dementia and mild cognitive impairment
Osama Sabri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Rats Harboring S284L Chrna4 Mutation Show Attenuation of Synaptic and Extrasynaptic GABAergic Transmission and Exhibit the Nocturnal Frontal Lobe Epilepsy Phenotype
Gang Zhu et al.
JOURNAL OF NEUROSCIENCE (2008)
Human nocturnal frontal lobe epilepsy:: Pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor β-subunit mutations outside the ion channel pore
Jean-Charles Hoda et al.
MOLECULAR PHARMACOLOGY (2008)
Effect of Intra-Amygdala Injection of Nicotine and GABA Receptor Agents on Anxiety-Like Behaviour in Rats
Mohammad-Reza Zarrindast et al.
PHARMACOLOGY (2008)
It is not either/or: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood
Marina R. Picciotto et al.
PROGRESS IN NEUROBIOLOGY (2008)
α7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease
Scott E. Counts et al.
ARCHIVES OF NEUROLOGY (2007)
Heterogeneity and complexity of native brain nicotinic receptors
Cecilia Gotti et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Sharon R. Grady et al.
BIOCHEMICAL PHARMACOLOGY (2007)
A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely
Wenli Gu et al.
NEUROSCIENCE LETTERS (2007)
Nigrostriatal damage preferentially decreases a subpopulation of α6β2*nAChRs in mouse, monkey, and Parkinson's disease striatum
Tanuja Bordia et al.
MOLECULAR PHARMACOLOGY (2007)
Quantification of nicotinic acetylcholine receptors in Parkinson's disease with 123I-5IA SPECT
Naoya Oishi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice
Yann S. Mineur et al.
NEUROPHARMACOLOGY (2007)
Anxiolytic effects of nicotine in zebrafish
Edward D. Levin et al.
PHYSIOLOGY & BEHAVIOR (2007)
alpha 4 beta 2 nicotinic receptor status in Alzheimer's disease using I-123-5IA-85380 single-photon-emission computed tomography
J. T. O'Brien et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice
R. L. Rabenstein et al.
PSYCHOPHARMACOLOGY (2006)
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial
F. Joseph McClernon et al.
PSYCHOPHARMACOLOGY (2006)
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease
Ahmadul Kadir et al.
PSYCHOPHARMACOLOGY (2006)
Sazetidine-a, a novel ligand that desensitizes α4β2 nicotinic acetylcholine receptors without activating them
Yingxian Xiao et al.
MOLECULAR PHARMACOLOGY (2006)
Epilepsy in North America: A report prepared under the auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization
William H. Theodore et al.
EPILEPSIA (2006)
Fragmentation of Golgi apparatus of nigral neurons with α-synuclein-positive inclusions in patients with Parkinson's disease
Yukio Fujita et al.
ACTA NEUROPATHOLOGICA (2006)
Genetic interaction between α4 and β2 subunits of high affinity nicotinic receptor:: analysis in schizophrenia
Vincenzo De Luca et al.
EXPERIMENTAL BRAIN RESEARCH (2006)
Increased sensitivity of the neuronal nicotinic receptor α2 subunit causes familial epilepsy with nocturnal wandering and ictal fear
Paolo Aridon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Genetics of chromosome 15q13-q14 in schizophrenia
Sherry Leonard et al.
BIOLOGICAL PSYCHIATRY (2006)
Brain neuronal nicotinic receptors as new targets for drug discovery
C Gotti et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
CNS localization of neuronal nicotinic receptors
Raad Nashmi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
alpha 7 nicotinic acetylcholine receptor expression in Alzheimer's disease - Receptor densities in brain regions of the APP((SWE)) mouse model and in human peripheral blood lymphocytes
Ian W. Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits
D Bertrand et al.
NEUROBIOLOGY OF DISEASE (2005)
Neuronal nicotinic acetylcholine receptors: Structural revelations, target identifications, and therapeutic inspirations
AA Jensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases.: An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus
IJ Bohr et al.
EXPERIMENTAL NEUROLOGY (2005)
Subunit composition of nicotinic receptors in monkey striatum: Effect of treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA
M Quik et al.
MOLECULAR PHARMACOLOGY (2005)
Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls
JE Strand et al.
EUROPEAN PSYCHIATRY (2005)
Loss of α-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum
M Quik et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Neuronal nicotinic receptors: from structure to pathology
C Gotti et al.
PROGRESS IN NEUROBIOLOGY (2004)
High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation
BJ Caldarone et al.
BIOLOGICAL PSYCHIATRY (2004)
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with lewy bodies, Parkinson's disease, and vascular dementia: In vitro binding study using 5-[I-125]-A-85380
SL Pimlott et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
LF Martin et al.
PSYCHOPHARMACOLOGY (2004)
Electrophysiological, pharmacological, and molecular evidence for α7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons
J Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Physiological roles of neuronal nicotinic receptor subtypes: New insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity
E Sher et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Neuronal Nicotinic Receptor Deficits in Alzheimer Patients with the Swedish Amyloid Precursor Protein 670/671 Mutation
Amelia Marutle et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Comparison of polymorphisms in the α7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects
J Gault et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy
A Rozycka et al.
EPILEPSIA (2003)
A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy
T Leniger et al.
EPILEPSIA (2003)
Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients
L Burghaus et al.
PARKINSONISM & RELATED DISORDERS (2003)
Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice
M Quik et al.
MOLECULAR PHARMACOLOGY (2003)
Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes
T Teaktong et al.
GLIA (2003)
Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease
ZZ Guan et al.
BRAIN RESEARCH (2002)
Declines in different β2*nicotinic receptor populations in monkey striatum after nigrostriatal damage
JM Kulak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Accelerated plaque accumulation, associative learning deficits, and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins
KT Dineley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurobiology of the nicotine withdrawal syndrome
PJ Kenny et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications
MR Picciotto et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Transdermal nicotine and haloperidol in Tourette's disorder: A double-blind placebo-controlled study
AA Silver et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses
S Cheeta et al.
PSYCHOPHARMACOLOGY (2001)
Predicting regular cigarette use among continuation high school students
S Skara et al.
AMERICAN JOURNAL OF HEALTH BEHAVIOR (2001)
Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety
C Labarca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications
MF Green et al.
BIOLOGICAL PSYCHIATRY (2001)
CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy
HA Phillips et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Cellular expression of α7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease -: A stereological approach
C Banerjee et al.
NEUROBIOLOGY OF DISEASE (2000)
Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)
RD Shytle et al.
BIOLOGICAL PSYCHIATRY (2000)
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia
CR Breese et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Expression of nicotinic acetylcholine receptors in Alzheimer's disease:: postmortem investigations and experimental approaches
A Wevers et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Mecamylamine in Tourette's syndrome: A two-year retrospective case study
AA Silver et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2000)
Neuronal nicotinic receptors in the human brain
D Paterson et al.
PROGRESS IN NEUROBIOLOGY (2000)
Comorbidity of psychiatric and substance abuse disorders
TP George et al.
CURRENT OPINION IN PSYCHIATRY (2000)
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases
E Perry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
5-iodo-A-85380, an alpha 4 beta 2 subtype-selective ligand for nicotinic acetylcholine receptors
AG Mukhin et al.
MOLECULAR PHARMACOLOGY (2000)
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
ZZ Guan et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Nicotine binding in human striatum: Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication
JA Court et al.
NEUROSCIENCE (2000)
Amyloid peptide A beta(1-42) binds selectively and with picomolar affinity to alpha 7 nicotinic acetylcholine receptors
HY Wang et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
